alt
Latest News
8 Things to Know About Johnson & Johnson's Janssen COVID-19 Vaccine
As the company announces that its single-dose Janssen COVID-19 Vaccine has been granted Emergency Use Authorization by the U.S. Food and Drug Administration, here are some key facts about how it works (hint: it involves an inactivated common cold virus), how it has been studied, how it would be transported—and more.
Today's Top Reads
Close
-
Did you like reading this story? Click the heart to show your love.
38 -
Did you like reading this story? Click the heart to show your love.
57 -
Did you like reading this story? Click on the heart to show your love.
8
Did you like reading this story? Click the heart to show your love.
1227
Learn about the innovative ways the company is mobilizing to help combat the global outbreak caused by the novel coronavirus.
More from Johnson & Johnson
-
June 07, 2023Together, they detail the company’s ongoing work in helping to create a healthier world, building a more diverse and inclusive workforce, championing global health equity and more.
-
April 18, 2023Check out this infographic breakdown of the company’s first-quarter 2023 performance, with key highlights from its Pharmaceutical, MedTech and Consumer Health businesses.
-
March 29, 2023The company has been recognized on the inaugural list for its innovative spirit—a trait that’s been at the heart of Johnson & Johnson's mission to improve health for people across the globe for over a century.
